I agree, and I think the private investment will be there. If you look at somebody like BioAmber, their facility is $80 million to $90 million. The rest of that funding will come from them. The money they have from the government is loans. It's not grant money.
The problem is that most of these start-up companies, when you look at their bond ratings, are rated triple-B or less. Well, banks will only touch you if you're double-B or higher. That's why there needs to be some methodology to help them get through that first construction. Once they have that, then the banks will probably be there, because that will probably move them to a double-B and then they'll get the funding; it's just getting that first facility.